-

TIVITY HEALTH 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Tivity Health, Inc. - TVTY

NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until April 27, 2020 to file lead plaintiff applications in a securities class action lawsuit against Tivity Health, Inc. (NasdaqGS: TVTY), if they purchased the Company’s securities between March 8, 2019, and February 19, 2020, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle District of Tennessee.

What You May Do

If you purchased securities of Tivity and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-tvty/ to learn more. If you wish to serve as a lead plaintiff in this class action by overseeing lead counsel with the goal of obtaining a fair and just resolution, you must request this position by application to the Court by April 27, 2020.

About the Lawsuit

Tivity and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On February 19, 2020, the Company announced its financial results for Q4 and YE 2019, disclosing that its “Nutrition segment had a disappointing end to 2019” including “a non-cash impairment charge of $377.1 million,” that contributed to a $272.8 million net loss in the fourth quarter, due to complications in the nutrition business since its acquisition of Nutrisystem in March 2019, and that its Chief Executive Officer had resigned.

On this news, the price of Tivity’s shares plummeted over 45%.

The case is Strougo v. Tivity Health, Inc. n, et al, 20cv165.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contacts

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850

Kahn Swick & Foti, LLC

NASDAQ:TVTY

Release Versions

Contacts

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850

More News From Kahn Swick & Foti, LLC

Olaplex Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olaplex Holdings, Inc. - OLPX

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Olaplex Holdings, Inc. (NasdaqGS: OLPX) to Henkel AG & Co. KGaA. Under the terms of the proposed transaction, shareholders of Olaplex will receive $2.06 in cash for each share of Olaplex that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequ...

Ultragenyx 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARE

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 6, 2026 to file lead plaintiff applications in a securities class action lawsuit against Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NasdaqGS: RARE), if they purchased or otherwise acquired the Company’s securities between August 3, 2023 and December 26, 2025, inclusive (the “Cl...

Calavo Growers Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Calavo Growers, Inc. - CVGW

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Calavo Growers, Inc. (NasdaqGS: CVGW) to Mission Produce, Inc. (NasdaqGS: AVO). Under the terms of the proposed transaction, shareholders of Calavo will receive $14.85 in cash and 0.9790 shares of Mission for each share of Calavo that they own. KSF is seeking to determine whether this consideration a...
Back to Newsroom